Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Tolperisone 50 mg	82
Overall Study	STARTED	Tolperisone 100 mg	87
Overall Study	STARTED	Tolperisone 150 mg	83
Overall Study	STARTED	Tolperisone 200 mg	85
Overall Study	STARTED	Placebo	78
Overall Study	COMPLETED	Tolperisone 50 mg	77
Overall Study	COMPLETED	Tolperisone 100 mg	83
Overall Study	COMPLETED	Tolperisone 150 mg	74
Overall Study	COMPLETED	Tolperisone 200 mg	77
Overall Study	COMPLETED	Placebo	72
Overall Study	NOT COMPLETED	Tolperisone 50 mg	5
Overall Study	NOT COMPLETED	Tolperisone 100 mg	4
Overall Study	NOT COMPLETED	Tolperisone 150 mg	9
Overall Study	NOT COMPLETED	Tolperisone 200 mg	8
Overall Study	NOT COMPLETED	Placebo	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03802565/flow